SIAA_NEIMB
ID SIAA_NEIMB Reviewed; 377 AA.
AC H2VFI5;
DT 03-APR-2013, integrated into UniProtKB/Swiss-Prot.
DT 21-MAR-2012, sequence version 1.
DT 25-MAY-2022, entry version 42.
DE RecName: Full=UDP-N-acetylglucosamine 2-epimerase;
DE EC=3.2.1.183;
GN Name=siaA; Synonyms=synX; OrderedLocusNames=NMB0070;
OS Neisseria meningitidis serogroup B (strain MC58).
OC Bacteria; Proteobacteria; Betaproteobacteria; Neisseriales; Neisseriaceae;
OC Neisseria.
OX NCBI_TaxID=122586;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=MC58;
RX PubMed=10710307; DOI=10.1126/science.287.5459.1809;
RA Tettelin H., Saunders N.J., Heidelberg J.F., Jeffries A.C., Nelson K.E.,
RA Eisen J.A., Ketchum K.A., Hood D.W., Peden J.F., Dodson R.J., Nelson W.C.,
RA Gwinn M.L., DeBoy R.T., Peterson J.D., Hickey E.K., Haft D.H.,
RA Salzberg S.L., White O., Fleischmann R.D., Dougherty B.A., Mason T.M.,
RA Ciecko A., Parksey D.S., Blair E., Cittone H., Clark E.B., Cotton M.D.,
RA Utterback T.R., Khouri H.M., Qin H., Vamathevan J.J., Gill J., Scarlato V.,
RA Masignani V., Pizza M., Grandi G., Sun L., Smith H.O., Fraser C.M.,
RA Moxon E.R., Rappuoli R., Venter J.C.;
RT "Complete genome sequence of Neisseria meningitidis serogroup B strain
RT MC58.";
RL Science 287:1809-1815(2000).
RN [2]
RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND
RP MUTAGENESIS OF ASP-100; GLU-122 AND ASP-131.
RC STRAIN=MC58;
RX PubMed=15518580; DOI=10.1021/bi048606d;
RA Murkin A.S., Chou W.K., Wakarchuk W.W., Tanner M.E.;
RT "Identification and mechanism of a bacterial hydrolyzing UDP-N-
RT acetylglucosamine 2-epimerase.";
RL Biochemistry 43:14290-14298(2004).
CC -!- FUNCTION: Catalyzes the conversion of UDP-N-acetylglucosamine (UDP-
CC GlcNAc) to UDP and N-acetyl-D-mannosamine (ManNAc).
CC {ECO:0000269|PubMed:15518580}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=H2O + UDP-N-acetyl-alpha-D-glucosamine = H(+) + N-acetyl-D-
CC mannosamine + UDP; Xref=Rhea:RHEA:30683, ChEBI:CHEBI:15377,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:17122, ChEBI:CHEBI:57705,
CC ChEBI:CHEBI:58223; EC=3.2.1.183;
CC Evidence={ECO:0000269|PubMed:15518580};
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Kinetic parameters:
CC KM=1.49 mM for UDP-N-acetyl-alpha-D-glucosamine
CC {ECO:0000269|PubMed:15518580};
CC Note=kcat is 4.7 sec(-1).;
CC -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:15518580}.
CC -!- SIMILARITY: Belongs to the UDP-N-acetylglucosamine 2-epimerase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE002098; AAF40537.1; -; Genomic_DNA.
DR PIR; A53384; A53384.
DR PIR; S60758; S60758.
DR RefSeq; NP_273134.1; NC_003112.2.
DR RefSeq; WP_002226892.1; NC_003112.2.
DR AlphaFoldDB; H2VFI5; -.
DR SMR; H2VFI5; -.
DR STRING; 122586.NMB0070; -.
DR PaxDb; H2VFI5; -.
DR EnsemblBacteria; AAF40537; AAF40537; NMB0070.
DR GeneID; 61282336; -.
DR KEGG; nme:NMB0070; -.
DR PATRIC; fig|122586.8.peg.104; -.
DR HOGENOM; CLU_061127_0_0_4; -.
DR OMA; VTYHPVT; -.
DR Proteomes; UP000000425; Chromosome.
DR GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro.
DR GO; GO:0008761; F:UDP-N-acetylglucosamine 2-epimerase activity; IEA:InterPro.
DR GO; GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IEA:InterPro.
DR InterPro; IPR020004; UDP-GlcNAc_Epase.
DR InterPro; IPR003331; UDP_GlcNAc_Epimerase_2_dom.
DR InterPro; IPR029767; WecB-like.
DR PANTHER; PTHR43174; PTHR43174; 1.
DR Pfam; PF02350; Epimerase_2; 1.
DR TIGRFAMs; TIGR03568; NeuC_NnaA; 1.
PE 1: Evidence at protein level;
KW Hydrolase; Isomerase; Reference proteome.
FT CHAIN 1..377
FT /note="UDP-N-acetylglucosamine 2-epimerase"
FT /id="PRO_0000421996"
FT ACT_SITE 212
FT /evidence="ECO:0000250"
FT MUTAGEN 100
FT /note="D->N: Strongly decreased activity."
FT /evidence="ECO:0000269|PubMed:15518580"
FT MUTAGEN 122
FT /note="E->Q: Strongly decreased activity."
FT /evidence="ECO:0000269|PubMed:15518580"
FT MUTAGEN 131
FT /note="D->Q: Strongly decreased activity."
FT /evidence="ECO:0000269|PubMed:15518580"
SQ SEQUENCE 377 AA; 42308 MW; D4289B3FA04EBB2B CRC64;
MKRILCITGT RADFGKLKPL LAYIENHPDL ELHLIVTGMH MMKTYGRTYK EVTRENYQHT
YLFSNQIQGE PMGAVLGNTI TFISRLSDEI EPDMVMIHGD RLEALAGAAV GALSSRLVCH
IEGGELSGTV DDSIRHSISK LSHIHLVANE QAVTRLVQMG EKRKHIHIIG SPDLDVMASS
TLPSLEEVKE YYGLPYENYG ISMFHPVTTE AHLMPQYAAQ YFKALELSGQ NIISIYPNND
TGTESILQEL LKYQSDKFIA FPSIRFEYFL VLLKHAKFMV GNSSAGIREA PLYGVPSIDV
GTRQSNRHMG KSIIHTDYET KNIFDAIQQA CSLGKFEADD TFNGGDTRTS TERFAEVINN
PETWNVSAQK RFIDLNL